Save over 40% on Gazyva - called Gazyvaro in Europe.
Non-english packaging is often present for European medicines- English label and English insert included. Plan in advance - allow us 7 days to ship this brand name medicine.
According to the European Medicines Agency, brand name Gazyvaro originating from Europe is manufactured at the following site(s):
Roche Pharma AG
Emil-Barell-Strasse 1
D-79639 Grenzach-Wyhlen
Germany
Information about Gazyva (Obinutuzumab)
Gazyva is a monoclonal antibody used in the treatment of certain types of hematologic malignancies. It is designed to target and deplete CD20-positive B cells, which are involved in the progression of various cancers.
Product Highlights
- FDA-approved for use in combination with chemotherapy for chronic lymphocytic leukemia (CLL) and for certain types of non-Hodgkin lymphoma (NHL).
- Treatment of adult patients with chronic lymphocytic leukemia (CLL) in combination with chlorambucil.
- Treatment of follicular lymphoma (FL) and other B-cell lymphomas in combination with other therapies.
Key Ingredient
Key Benefits
- Induces cell death in B cells through multiple mechanisms, including antibody-dependent cellular cytotoxicity (ADCC).
- Enhances the effectiveness of chemotherapy when used in combination.
- Provides a treatment option for patients with previously untreated or relapsed B-cell malignancies.
Direction of Use
- Administered by intravenous infusion; the dosage and schedule depend on the specific indication and treatment regimen.
- Pre-medication may be required to minimize infusion-related reactions.
Safety Concerns
- Potential side effects include infusion-related reactions, infections, and hematologic toxicities (e.g., low blood cell counts).
- Patients should be monitored for signs of infusion reactions and infections during and after treatment.
Avoid Gazyva (Obinutuzumab) If
- You have a known hypersensitivity to obinutuzumab or any components of the formulation.
- You have active severe infections or a history of certain viral infections, such as hepatitis B.
- You are pregnant or planning to become pregnant without consulting a healthcare provider.
